| Keywords: |
adult; treatment outcome; middle aged; clinical feature; case report; dose response; letter; midazolam; melphalan; amyloidosis; stem cell transplantation; hematopoietic stem cell transplantation; cryopreservation; dimethyl sulfoxide; peripheral blood stem cell; heart failure; hepatomegaly; antineoplastic agents, alkylating; stem cells; hematopoiesis; morphine; echocardiography; cardiomyopathies; granulocyte colony stimulating factor; dipeptidyl carboxypeptidase inhibitor; antigens, cd34; proteinuria; hydration; heart amyloidosis; diuretic agent; leukapheresis; amyloid; autotransplantation; amiodarone; heart ejection fraction; dobutamine; heart left ventricle enddiastolic pressure; blood transfusion, autologous; blood storage; bence jones protein; cardiogenic shock; humans; prognosis; human; male; priority journal; heart muscle biopsy; shock, cardiogenic
|
